Endo-ERN webinar: Overgrowth syndromes Beckwith Wiedemann syndrome and other rare conditions

This webinar took place on September 7th, 2021

On Tuesday September 7th at 17:00 – 18:00 CET an Endo-ERN webinar about “Overgrowth syndromes: Beckwith Wiedemann syndrome and other rare conditions” will be given by Frédéric Brioude from Hôpital Armand-Trousseau in France.

Overgrowth syndromes are a heterogeneous group of rare disorders characterized by generalized or segmental excessive growth, that can be associated with other features, including macrocephaly or cognitive impairment. These syndromes are caused by either genetic or epigenetic anomalies affecting factors involved in cell proliferation and/or the regulation of epigenetic markers. Overgrowth syndromes are frequently associated with an increased risk of cancer (embryonic tumours during infancy or carcinomas [...]

Continue reading →

Vacancies: Phd positions – Better estimates of hormonal exposure to improve diagnosis and treatment in endocrine diseases (BEED-ED)

Posted on

Are you interested in improving hormone measurements and implement your research findings into clinical practice?

In a joint research project, the departments of Endocrinology at Ghent University and KU Leuven are currently hiring two enthusiastic and highly motivated PhD researchers to participate in our new research project “Better estimates of hormonal exposure to improve diagnosis and treatment in endocrine diseases”. This project is funded by the TBM program of FWO Vlaanderen (Applied Biomedical Research with primary social finality) for a period of 4 years and will start October, 1st 2021.

Continue reading →

This entry was posted in General.

Endo-ERN General Assembly 2022

This event took place from February 15th to February 16th, 2022

The Endo-ERN General Assembly 2022 will be virtually held on Tuesday & Wednesday 15 & 16th of February 2022.

 

Tuesday 15th of February 2022

09:30 – 10:30 hrs Steering Committee & Advisory Board meeting
11.00 – 12.45 hrs GENERAL ASSEMBLY
13:30 – 16:00 hrs Meet and interact with your MTG co-workers

Wednesday 16th of February 2022

10:00 – 11:45 hrs GENERAL ASSEMBLY
12:30 – 15:00 hrs Meet and interact with your MTG co-workers

Continue reading →

Prestigious EJPRD ERN Research Mobility Fellowship for drs. Eva Coopmans and drs. Oana Danila

Posted on

The Research Mobility Fellowships of the European Joint Program on Rare Diseases (EJP RD) – The European Reference Networks (ERN) are awarded twice a year to a leading physician or researcher to gain new competencies and expertise in a European institution that specializes in research on rare diseases.

Eva Coopmans is a physician and researcher at the Center for Endocrine Tumors Leiden under the supervision of Prof. A.M. Pereira Arias and Prof. N.R. Biermasz. She received the EJP RD – ERN fellowship for ‘GH-secreting pituitary tumours: nip therapy resistance in the bud (pilot study)’. With this fellowship she can address [...]

Continue reading →

This entry was posted in General.

Endo-ERN webinar: Update on the management of 46,XX Ovarian Dysgenesis and Primary Ovarian Insufficiency

This webinar took place on September 9th, 2021

On Thursday September 9th at 15:00 – 16:00 CET an Endo-ERN webinar about “Update on the management of 46,XX Ovarian Dysgenesis and Primary Ovarian Insufficiency” will be given by Philippe Touraine from APHP-Pitié Salpêtrière Hospital in France.

Primary (premature) ovarian insufficiency (POI) is defined as a loss of ovarian activity before the age of 40, and is characterized by menstrual disturbances (amenorrhea or oligomenorrhea) with elevated gonadotropins (follicle-stimulating hormone [FSH] ≥ 25 IU/L) and low serum estradiol levels.The incidence of POI is around 1 per 100 women overall, and 1 per 1000 women under the age of 30 years. POI [...]

Continue reading →

Endo-ERN webinar: Update on congenital hyperinsulinism

This webinar took place on July 6th, 2021

On Tuesday July 6th at 16:00 – 17:00 CET an Endo-ERN webinar about “Update on congenital hyperinsulinism” will be given by Oliver Blankenstein, Peter Kühnen, Sebastian Kummer, Alena Welters and Thomas Meissner from Charité – Universitätsmedizin Berlin / Universitätsklinikum Düsseldorf.

Congenital hyperinsulinism is the most frequent cause of severe transient and persistent neonatal hypoglycemia. The etiology and the clinical course are highly variable. Today, we still find a high proportion of patients suffering from hypoglycemic brain damage.

This update will focus on the rational approach to evaluation and management of a patient with suspected hyperinsulinism. Efforts to improve the [...]

Continue reading →

Resource Webinar: hPSCreg

This webinar took place on June 21st, 2021

As part of the EJP RD Resource Webinar series, the next webinar will be dedicated to hPSCreg and will be held on June 21st.

The human pluripotent stem cell registry (hPSCreg) maintains resources to track the usage of human embryonic and induced pluripotent stem cell lines from research to clinical applications. Participants will be given an overview of hPSCreg from different stakeholder perspectives (basic and translational researchers, industry, and funders) and will learn about what data is available for each registered line and the benefits of registering lines in hPSCreg.

Continue reading →